This is a preview of subscription content, log in via an institution to check access.
Notes
Global Alliance for Vaccines and Immunization
Reference
Debellut F, et al. Evaluating the potential economic and health impact of rotavirus vaccination in 63 middle-income countries not eligible for Gavi funding: a modelling study. The Lancet Global Health : 24 May 2021. Available from: URL: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00167-4/fulltext
Rights and permissions
About this article
Cite this article
Rotavirus vaccination likely cost effective in many middle-income countries. PharmacoEcon Outcomes News 879, 25 (2021). https://doi.org/10.1007/s40274-021-7748-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7748-2